[Anti-obesity drugs and potential changes in the epidemiology of this condition and in cardiovascular risk factors]. [PDF]
Cuatrecasas G.
europepmc +1 more source
Correction: Consensus statement on standardizing CGM evaluation metrics in Latin america: an expert approach. [PDF]
Scharf M +9 more
europepmc +1 more source
PpDof 5 es un regulador de la expresión de los genes de glutamina sintetasa de pino tanto en tejidos fotosintéticos como no fotosintéticos. Hemos utilizado Arabidopsis thalianacomo un sistema modelo para estudiar la función de PpDof 5 en planta ...
Canales, Javier +4 more
core
Infertility as a possible diagnostic feature of Carney complex. [PDF]
Knoblovits P +5 more
europepmc +1 more source
Metabolismo de las Bacterias Heterótrofas
En este video se muestra el metabolismo de las bacterias heterótrofas en una EDAR (Estación de Depuración de Aguas Residuales). Se muestra los procesos de crecimiento, diferenciando en catabolismo y anabolismo, de muerte celular y de hidrólisis.
Barat, Ramón +1 more
core
[Technical quality of cardiopulmonary resuscitation after a training intervention and its association with anthropometric variables]. [PDF]
Peña-Otero D +4 more
europepmc +1 more source
Metabolismo degli acidi grassi
Il volume, promosso dalla Società Italiana di Chimica Agraria, rappresenta l’opportunità di offrire agli studenti, in particolare dei corsi di studio triennali dell’area agraria e forestale, uno strumento didattico capace di fornire le basi necessarie ...
Vischetti, C. +3 more
core
[SEIOMM-SEMERGEN-semFYC-SEMG recommendations for the management of patients with osteoporosis/fragility fracture in primary care]. [PDF]
Carbonell-Abella C +5 more
europepmc +1 more source
Methanol intoxication and acute kidney injury: pathophysiological mechanisms and therapeutic approaches. [PDF]
Nogueira GN +5 more
europepmc +1 more source
Study of metabolic stability and toxicity of the drug candidate 02004
reservedIl composto 02004 (PM = 467,2805 Da), caratterizzato da elevata lipofilicità, è attualmente in corso di valutazione preclinica come candidato farmaco antitumorale. Tale fase di sperimentazione permette di ottenere le informazioni necessarie per
MEGA, AMEDEO
core

